CX3CL1 and inflammation: The production of lung fibroblast-derived CX3CL1 were obviously reduced by specific inhibitors of the STAT-1 transcription factor, supporting the hypothesis that lung fibroblasts are an important cellular source of CX3CL1 and may contribute to causing pulmonary inflammation and fibrosis [153].